Clinical Trial

Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers

Name: Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers — clinical trial record (NCT06736587)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The safety and tolerability of single and multiple administration of DWP212525

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-12-13; most recent amendment 2026-06-03.

Trial Details

NCT Number	NCT06736587
Lead Sponsor	Daewoong Pharmaceutical Co. LTD.
Conditions	Autoimmune Diseases
Enrollment	84 participants
Start Date	2024-12-10
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-08